OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
+11.15%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$106M
AUM Growth
+$106M
(+4.4%)
Cap. Flow
-$144M
Cap. Flow
% of AUM
-136.18%
Top 10 Holdings %
Top 10 Hldgs %
90.76%
Holding
29
New
4
Increased
3
Reduced
9
Closed
2
Top Buys
| 1 |
QuidelOrtho
QDEL
|
$4.1M |
| 2 |
Opko Health
OPK
|
$3.04M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$2.62M |
| 4 |
Surgery Partners
SGRY
|
$675K |
| 5 |
Palantir
PLTR
|
$563K |
Top Sells
| 1 |
GeneDx Holdings
WGS
|
$146M |
| 2 |
DMTK
DermTech, Inc. Common Stock
DMTK
|
$2.21M |
| 3 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$1.76M |
| 4 |
AGEN
Agenus
AGEN
|
$1.42M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
$1.12M |
Sector Composition
| 1 | Healthcare | 98.48% |
| 2 | Energy | 0.59% |
| 3 | Technology | 0.53% |
| 4 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Pacific Biosciences
PACB
$393M
| $26.8M | 19.75% |
2,015,495
| – | – |
|
|
2
QuidelOrtho
QDEL
$1.95B
| $20.3M | 14.99% |
245,495
+49,487
| +25% | +$4.1M |
|
3
Biohaven
BHVN
$1.63B
| $14.3M | 10.54% |
597,773
-37,703
| -6% | -$902K |
|
|
4
Opko Health
OPK
$1.1B
| $9.21M | 6.78% |
4,242,465
+1,399,300
| +49% | +$3.04M |
|
|
MRTX
5
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $5.51M | 4.06% |
152,600
-48,800
| -24% | -$1.76M |
|
|
6
GeneDx Holdings
WGS
$3.72B
| $5.16M | 3.8% |
865,849
-24,462,208
| -97% | -$146M |
|
|
AGEN
7
Agenus
AGEN
$133M
| $4.89M | 3.6% |
3,056,460
-888,650
| -23% | -$1.42M |
|
8
BioCryst Pharmaceuticals
BCRX
$1.74B
| $3.91M | 2.88% |
555,522
| – | – |
|
9
Forian
FORA
$61.3M
| $3.34M | 2.46% |
1,364,329
| – | – |
|
|
BPMC
10
DELISTED
Blueprint Medicines
BPMC
| $2.62M | 1.93% |
+41,377
| New | +$2.62M |
|
11
Ardelyx
ARDX
$1.53B
| $2.37M | 1.75% |
699,700
-10,000
| -1% | -$33.9K |
|
|
IMMP
12
Immutep
IMMP
$234M
| $1.89M | 1.39% |
894,391
-456,411
| -34% | -$963K |
|
|
AXDX
13
DELISTED
Accelerate Diagnostics
AXDX
| $1.22M | 0.9% |
1,510,654
| – | – |
|
|
OMGA
14
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $1.11M | 0.81% |
197,449
-136,387
| -41% | -$764K |
|
15
Biogen
BIIB
$19.4B
| $687K | 0.51% |
2,412
| – | – |
|
|
16
Surgery Partners
SGRY
$2.91B
| $675K | 0.5% |
+15,000
| New | +$675K |
|
|
VTNR
17
DELISTED
Vertex Energy, Inc
VTNR
| $628K | 0.46% |
100,400
+50,400
| +101% | +$315K |
|
|
18
Palantir
PLTR
$372B
| $563K | 0.41% |
+36,700
| New | +$563K |
|
19
ProShares UltraPro QQQ
TQQQ
$26B
| $414K | 0.31% |
70,000
-70,000
| -50% | -$414K |
|
|
DMTK
20
DELISTED
DermTech, Inc. Common Stock
DMTK
| $124K | 0.09% |
47,687
-849,762
| -95% | -$2.21M |
|
21
MiNK Therapeutics
INKT
$64.4M
| $106K | 0.08% |
+50,461
| New | +$106K |
|
22
FibroGen
FGEN
$47.8M
| – | – |
0
| – | – |
|
23
McKesson
MCK
$85.4B
| – | – |
0
| – | – |
|
24
Seres Therapeutics
MCRB
$166M
| – | – |
0
| – | – |
|
|
SWTX
25
DELISTED
SpringWorks Therapeutics
SWTX
| – | – |
-43,500
| Closed | -$1.12M |
|